Methyl 2-Bromothiazole-5-carboxylate>95.0%(GC)1g

benzyl 3-fluoro-4,4-dihydroxypiperidine-1-carboxylate, 97.0%, 1g

Ethyl 1-methyl-1H-benzo[d][1,2,3]triazole-5-carboxylate, 95.0%, 250mg

4-(4-Carboxy-[1,2,3]triazol-1-yl)-piperidine-1-carboxylic acid tert-butyl ester, 25g

Polvo de zinc, mínimo 98 %, <63 µm, estabilizado, 1 kg, envase de vidrio

2,3,4,5-Tetrahydro-1H-1,5-methanobenzo[d]azepine hydrochloride, 95.0%, 5g

2-Chloro-6-ethoxyquinazoline, 97%, 100mg

1-[4-Methyl-2-(2-phenylethynyl)phenyl]-2,3-butadien-1-one, 1g

8-propyl-4-(pyridine-3-carbonyl)-1-oxa-4,8-diazaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

2-Fluoro-6-methylbenzaldehyde, 95.0%, 10g

4-Amino-3,5-diisopropylbenzoic acid, 98%, 10g

tert-Butyl 4-(pyridine-5-sulfonamido)piperidine-1-carboxylate, 95.0%, 1g

Diallyldimethylammonium Chloride (60% in Water)500mL